{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:31:22Z","timestamp":1789731082993,"version":"4.0.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T00:00:00Z","timestamp":1729296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T00:00:00Z","timestamp":1729296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-024-01559-4","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T21:02:28Z","timestamp":1729285348000},"page":"1249-1262","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["\u03b2-Sitosterol Mitigates Apoptosis, Oxidative Stress and Inflammatory Response by Inactivating TLR4\/NF-\u043aB Pathway in Cell Models of Diabetic Nephropathy"],"prefix":"10.1007","volume":"83","author":[{"given":"Shengnan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,19]]},"reference":[{"key":"1559_CR1","volume":"2019","author":"Y Xiong","year":"2019","unstructured":"Xiong, Y., & Zhou, L. (2019). The signaling of cellular senescence in diabetic nephropathy. Oxidative Medicine and Cellular Longevity, 2019, 7495629.","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"1","key":"1559_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000333249","volume":"2","author":"JP Dwyer","year":"2012","unstructured":"Dwyer, J. P., Parving, H. H., Hunsicker, L. G., Ravid, M., Remuzzi, G., & Lewis, J. B. (2012). Renal dysfunction in the presence of normoalbuminuria in type 2 diabetes: Results from the DEMAND study. Cardiorenal Medicine, 2(1), 1\u201310.","journal-title":"Cardiorenal Medicine"},{"key":"1559_CR3","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/1497449","volume":"2021","author":"N Samsu","year":"2021","unstructured":"Samsu, N. (2021). Diabetic nephropathy: Challenges in pathogenesis, diagnosis, and treatment. BioMed Research International, 2021, 1497449.","journal-title":"BioMed Research International"},{"issue":"1","key":"1559_CR4","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-46270-1","volume":"13","author":"H Riedmann","year":"2023","unstructured":"Riedmann, H., Kayser, S., Helmst\u00e4dter, M., Epting, D., & Bergmann, C. (2023). Kif21a deficiency leads to impaired glomerular filtration barrier function. Scientific Reports, 13(1), 19161.","journal-title":"Scientific Reports"},{"issue":"7","key":"1559_CR5","first-page":"990","volume":"82","author":"YW Xing","year":"2021","unstructured":"Xing, Y. W., & Liu, K. Z. (2021). Azithromycin inhibited oxidative stress and apoptosis of high glucose-induced podocytes by inhibiting STAT1 pathway. Drug Development Research, 82(7), 990\u2013998.","journal-title":"Drug"},{"key":"1559_CR6","doi-asserted-by":"crossref","first-page":"110702","DOI":"10.1016\/j.biopha.2020.110702","volume":"131","author":"S Babu","year":"2020","unstructured":"Babu, S., & Jayaraman, S. (2020). An update on \u03b2-sitosterol: A potential herbal nutraceutical for diabetic management. Biomedicine & Pharmacotherapy, 131, 110702.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"3","key":"1559_CR7","doi-asserted-by":"crossref","first-page":"276","DOI":"10.2174\/0929866527666200813204833","volume":"28","author":"Y Leng","year":"2021","unstructured":"Leng, Y., Sun, Y., Lv, C., Li, Z., Yuan, C., & Zhang, J., et al. (2021). Characterization of \u03b2-Sitosterol for Potential Selective GR Modulation. Protein and Peptide Letters, 28(3), 276\u2013281.","journal-title":"Protein and Peptide Letters"},{"key":"1559_CR8","volume":"2020","author":"Y Sun","year":"2020","unstructured":"Sun, Y., Gao, L., Hou, W., & Wu, J. (2020). \u03b2-sitosterol alleviates inflammatory response via inhibiting the activation of ERK\/p38 and NF-\u03baB pathways in LPS-exposed BV2 cells. BioMed Research International, 2020, 7532306.","journal-title":"BioMed Research International"},{"issue":"5","key":"1559_CR9","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/mnfr.201300433","volume":"58","author":"KA Kim","year":"2014","unstructured":"Kim, K. A., Lee, I. A., Gu, W., Hyam, S. R., & Kim, D. H. (2014). \u03b2-Sitosterol attenuates high-fat diet-induced intestinal inflammation in mice by inhibiting the binding of lipopolysaccharide to toll-like receptor 4 in the NF-\u03baB pathway. Molecular Nutrition & Food Research, 58(5), 963\u2013972.","journal-title":"Molecular Nutrition & Food Research"},{"issue":"1","key":"1559_CR10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1753-0407.2010.00107.x","volume":"3","author":"R Gupta","year":"2011","unstructured":"Gupta, R., Sharma, A. K., Dobhal, M. P., Sharma, M. C., & Gupta, R. S. (2011). Antidiabetic and antioxidant potential of \u03b2-sitosterol in streptozotocin-induced experimental hyperglycemia. Journal of Diabetes, 3(1), 29\u201337.","journal-title":"Journal of Diabetes"},{"key":"1559_CR11","volume":"2021","author":"S Ding","year":"2021","unstructured":"Ding, S., Wang, W., Song, X., & Ma, H. (2021). Based on network pharmacology and molecular docking to explore the underlying mechanism of Huangqi Gegen decoction for treating diabetic nephropathy. Evidence-Based Complementary and Alternative Medicine: eCAM., 2021, 9928282.","journal-title":"Evidence-Based Complementary and Alternative Medicine: eCAM."},{"issue":"1","key":"1559_CR12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12906-022-03662-6","volume":"22","author":"S Fu","year":"2022","unstructured":"Fu, S., Zhou, Y., Hu, C., Xu, Z., & Hou, J. (2022). Network pharmacology and molecular docking technology-based predictive study of the active ingredients and potential targets of rhubarb for the treatment of diabetic nephropathy. BMC Complementary Medicine and Therapies, 22(1), 210.","journal-title":"BMC Complementary Medicine and Therapies"},{"issue":"4","key":"1559_CR13","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s11481-023-10091-w","volume":"18","author":"Y Zheng","year":"2023","unstructured":"Zheng, Y., Zhao, J., Chang, S., Zhuang, Z., Waimei, S., & Li, X., et al. (2023). \u03b2-sitosterol alleviates neuropathic pain by affect microglia polarization through inhibiting TLR4\/NF-\u03baB signaling pathway. Journal of Neuroimmune Pharmacology, 18(4), 690\u2013703.","journal-title":"Journal of Neuroimmune Pharmacology"},{"issue":"1","key":"1559_CR14","volume":"51","author":"L Zhu","year":"2018","unstructured":"Zhu, L., Han, J., Yuan, R., Xue, L., & Pang, W. (2018). Berberine ameliorates diabetic nephropathy by inhibiting TLR4\/NF-\u03baB pathway. Biological Research, 51(1), 9.","journal-title":"Biological Research"},{"issue":"1","key":"1559_CR15","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/13880209.2023.2174145","volume":"61","author":"F Wang","year":"2023","unstructured":"Wang, F., Liu, C., Ren, L., Li, Y., Yang, H., & Yu, Y., et al. (2023). Sanziguben polysaccharides improve diabetic nephropathy in mice by regulating gut microbiota to inhibit the TLR4\/NF-\u03baB\/NLRP3 signalling pathway. Pharmaceutical Biology, 61(1), 427\u2013436.","journal-title":"Pharmaceutical Biology"},{"key":"1559_CR16","volume":"108","author":"D Qiu","year":"2023","unstructured":"Qiu, D., Song, S., Chen, N., Bian, Y., Yuan, C., & Zhang, W., et al. (2023). NQO1 alleviates renal fibrosis by inhibiting the TLR4\/NF-\u03baB and TGF-\u03b2\/Smad signaling pathways in diabetic nephropathy. Cellular Signalling, 108, 110712.","journal-title":"Cellular Signalling"},{"key":"1559_CR17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.biopha.2018.09.007","volume":"108","author":"X Chen","year":"2018","unstructured":"Chen, X., Zhao, L., Xing, Y., & Lin, B. (2018). Down-regulation of microRNA-21 reduces inflammation and podocyte apoptosis in diabetic nephropathy by relieving the repression of TIMP3 expression. Biomedicine & Pharmacotherapy, 108, 7\u201314.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"1","key":"1559_CR18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-62579-7","volume":"10","author":"A Mima","year":"2020","unstructured":"Mima, A., Yasuzawa, T., Nakamura, T., & Ueshima, S. (2020). Linagliptin affects IRS1\/Akt signaling and prevents high glucose-induced apoptosis in podocytes. Scientific Reports, 10(1), 5775.","journal-title":"Scientific Reports"},{"key":"1559_CR19","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.2147\/DMSO.S276184","volume":"13","author":"W Xue","year":"2020","unstructured":"Xue, W., Mao, J., Chen, Q., Ling, W., & Sun, Y. (2020). Mogroside IIIE alleviates high glucose-induced inflammation, oxidative stress and apoptosis of podocytes by the activation of AMPK\/SIRT1 signaling pathway. Diabetes, Metabolic Syndrome and Obesity, 13, 3821\u20133830.","journal-title":"Diabetes, Metabolic Syndrome and Obesity"},{"key":"1559_CR20","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3389\/fendo.2019.00603","volume":"10","author":"Y Wang","year":"2019","unstructured":"Wang, Y., Zhu, X., Yuan, S., Wen, S., Liu, X., & Wang, C., et al. (2019). TLR4\/NF-\u03baB signaling induces GSDMD-related pyroptosis in tubular cells in diabetic kidney disease. Frontiers in Endocrinology, 10, 603.","journal-title":"Frontiers in Endocrinology"},{"issue":"3","key":"1559_CR21","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.3892\/mmr.2020.11317","volume":"22","author":"L Chen","year":"2020","unstructured":"Chen, L., Wang, Y., Luan, H., Ma, G., Zhang, H., & Chen, G. (2020). DUSP6 protects murine podocytes from high glucose\u2011induced inflammation and apoptosis. Molecular Medicine Reports, 22(3), 2273\u20132282.","journal-title":"Molecular Medicine Reports"},{"issue":"19","key":"1559_CR22","doi-asserted-by":"crossref","first-page":"10822","DOI":"10.3390\/ijms221910822","volume":"22","author":"A Winiarska","year":"2021","unstructured":"Winiarska, A., Knysak, M., Nabrdalik, K., Gumprecht, J., & Stomp\u00f3r, T. (2021). Inflammation and oxidative stress in diabetic kidney disease: The targets for SGLT2 inhibitors and GLP-1 receptor agonists. International Journal of Molecular Sciences, 22(19), 10822.","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"1559_CR23","doi-asserted-by":"crossref","first-page":"e6839","DOI":"10.5867\/medwave.2017.01.6839","volume":"17","author":"CE Meza Letelier","year":"2017","unstructured":"Meza Letelier, C. E., San Mart\u00edn Ojeda, C. A., Ruiz Provoste, J. J., & Frugone Zaror, C. J. (2017). [Pathophysiology of diabetic nephropathy: A literature review]. Medwave, 17(1), e6839.","journal-title":"Medwave"},{"key":"1559_CR24","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.phymed.2018.10.031","volume":"54","author":"H Xue","year":"2019","unstructured":"Xue, H., Li, P., Luo, Y., Wu, C., Liu, Y., & Qin, X., et al. (2019). Salidroside stimulates the Sirt1\/PGC-1\u03b1 axis and ameliorates diabetic nephropathy in mice. Phytomedicine, 54, 240\u2013247.","journal-title":"Phytomedicine"},{"key":"1559_CR25","doi-asserted-by":"crossref","first-page":"110684","DOI":"10.1016\/j.biopha.2020.110684","volume":"131","author":"Y Guo","year":"2020","unstructured":"Guo, Y., Ran, Z., Zhang, Y., Song, Z., Wang, L., & Yao, L., et al. (2020). Marein ameliorates diabetic nephropathy by inhibiting renal sodium glucose transporter 2 and activating the AMPK signaling pathway in db\/db mice and high glucose-treated HK-2 cells. Biomedicine & Pharmacotherapy, 131, 110684.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"1","key":"1559_CR26","volume":"10","author":"Y Zhong","year":"2019","unstructured":"Zhong, Y., Lee, K., Deng, Y., Ma, Y., Chen, Y., & Li, X., et al. (2019). Arctigenin attenuates diabetic kidney disease through the activation of PP2A in podocytes. Nature Communications, 10(1), 4523.","journal-title":"Nature Communications"},{"issue":"12","key":"1559_CR27","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.17219\/acem\/104534","volume":"28","author":"P Podg\u00f3rski","year":"2019","unstructured":"Podg\u00f3rski, P., Konieczny, A., Lis, \u0141., Witkiewicz, W., & Hruby, Z. (2019). Glomerular podocytes in diabetic renal disease. Advances in Clinical and Experimental Medicine, 28(12), 1711\u20131715.","journal-title":"Advances in Clinical and Experimental Medicine"},{"key":"1559_CR28","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.bbrc.2020.11.061","volume":"534","author":"L Xing","year":"2021","unstructured":"Xing, L., Guo, H., Meng, S., Zhu, B., Fang, J., & Huang, J., et al. (2021). Klotho ameliorates diabetic nephropathy by activating Nrf2 signaling pathway in podocytes. Biochemical and Biophysical Research Communications, 534, 450\u2013456.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"Suppl 4","key":"1559_CR29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/nep.13451","volume":"23","author":"CW Tung","year":"2018","unstructured":"Tung, C. W., Hsu, Y. C., Shih, Y. H., Chang, P. J., & Lin, C. L. (2018). Glomerular mesangial cell and podocyte injuries in diabetic nephropathy. Nephrology, 23(Suppl 4), 32\u201337.","journal-title":"Nephrology"},{"key":"1559_CR30","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.2147\/DMSO.S305092","volume":"14","author":"X Quan","year":"2021","unstructured":"Quan, X., Liu, H., Ye, D., Ding, X., & Su, X. (2021). Forsythoside A alleviates high glucose-induced oxidative stress and inflammation in podocytes by inactivating MAPK signaling via MMP12 inhibition. Diabetes, Metabolic Syndrome and Obesity, 14, 1885\u20131895.","journal-title":"Diabetes, Metabolic Syndrome and Obesity"},{"issue":"2","key":"1559_CR31","doi-asserted-by":"crossref","first-page":"260","DOI":"10.4239\/wjd.v15.i2.260","volume":"15","author":"YX He","year":"2024","unstructured":"He, Y. X., Wang, T., Li, W. X., & Chen, Y. X. (2024). Long noncoding RNA protein-disulfide isomerase-associated 3 regulated high glucose-induced podocyte apoptosis in diabetic nephropathy through targeting miR-139-3p. World Journal of Diabetes, 15(2), 260\u2013274.","journal-title":"World Journal of Diabetes"},{"issue":"3","key":"1559_CR32","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/jdi.14116","volume":"15","author":"R Zheng","year":"2024","unstructured":"Zheng, R., Xu, Q., Wang, Y., Zhong, Y., & Zhu, R. (2024). Cordyceps cicadae polysaccharides attenuate diabetic nephropathy via the miR-30a-3p\/TRIM16 axis. Journal of Diabetes Investigation, 15(3), 300\u2013314.","journal-title":"Journal of Diabetes Investigation"},{"key":"1559_CR33","volume":"2020","author":"W Huang","year":"2020","unstructured":"Huang, W., Man, Y., Gao, C., Zhou, L., Gu, J., & Xu, H., et al. (2020). Short-chain fatty acids ameliorate diabetic nephropathy via GPR43-mediated inhibition of oxidative stress and NF-\u03baB signaling. Oxidative Medicine and Cellular Longevity, 2020, 4074832.","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"1559_CR34","volume":"278","author":"Q Zhang","year":"2021","unstructured":"Zhang, Q., Hu, Y., Hu, J. E., Ding, Y., Shen, Y., & Xu, H., et al. (2021). Sp1-mediated upregulation of Prdx6 expression prevents podocyte injury in diabetic nephropathy via mitigation of oxidative stress and ferroptosis. Life Science, 278, 119529.","journal-title":"Life Science"},{"key":"1559_CR35","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.molmet.2019.02.007","volume":"23","author":"H Yang","year":"2019","unstructured":"Yang, H., Xie, T., Li, D., Du, X., Wang, T., & Li, C., et al. (2019). Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-\u03baB\/TNF-\u03b1 pathway. Molecular Metabolism, 23, 24\u201336.","journal-title":"Molecular Metabolism"},{"issue":"3","key":"1559_CR36","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00210-020-01984-1","volume":"394","author":"K Koc","year":"2021","unstructured":"Koc, K., Geyikoglu, F., Cakmak, O., Koca, A., Kutlu, Z., & Aysin, F., et al. (2021). The targets of \u03b2-sitosterol as a novel therapeutic against cardio-renal complications in acute renal ischemia\/reperfusion damage. Naunyn-Schmiedeberg\u2019s. Archives of Pharmacology, 394(3), 469\u2013479.","journal-title":"Archives of Pharmacology"},{"key":"1559_CR37","volume":"2023","author":"Y Chen","year":"2023","unstructured":"Chen, Y., He, S., Zeng, A., He, S., Jin, X., & Li, C., et al. (2023). Inhibitory effect of \u03b2-sitosterol on the Ang II-induced proliferation of A7r5 aortic smooth muscle cells. Analytical Cellular Pathology, 2023, 2677020.","journal-title":"Analytical Cellular Pathology"},{"key":"1559_CR38","volume":"14","author":"D Zhang","year":"2023","unstructured":"Zhang, D., Ge, F., Ji, J., Li, Y. J., Zhang, F. R., & Wang, S. Y., et al. (2023). \u03b2-sitosterol alleviates dextran sulfate sodium-induced experimental colitis via inhibition of NLRP3\/Caspase-1\/GSDMD-mediated pyroptosis. Frontiers in Pharmacology, 14, 1218477.","journal-title":"Frontiers in Pharmacology"},{"issue":"3","key":"1559_CR39","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.psj.2019.10.025","volume":"99","author":"Y Cheng","year":"2020","unstructured":"Cheng, Y., Chen, Y., Li, J., Qu, H., Zhao, Y., & Wen, C., et al. (2020). Dietary \u03b2-sitosterol regulates serum lipid level and improves immune function, antioxidant status, and intestinal morphology in broilers. Poultry Science, 99(3), 1400\u20131408.","journal-title":"Poultry Science"},{"key":"1559_CR40","volume":"243","author":"C Li","year":"2020","unstructured":"Li, C., Guan, X. M., Wang, R. Y., Xie, Y. S., Zhou, H., & Ni, W. J., et al. (2020). Berberine mitigates high glucose-induced podocyte apoptosis by modulating autophagy via the mTOR\/P70S6K\/4EBP1 pathway. Life Science, 243, 117277.","journal-title":"Life Science"},{"issue":"2","key":"1559_CR41","first-page":"66","volume":"11","author":"EF Carney","year":"2015","unstructured":"Carney, E. F. (2015). Glomerular disease: Autophagy failure and mitochondrial dysfunction in FSGS. Nature Reviews, Nephrology, 11(2), 66.","journal-title":"Nature Reviews, Nephrology"},{"key":"1559_CR42","volume":"957","author":"Y Chen","year":"2023","unstructured":"Chen, Y., Yin, S., Liu, R., Yang, Y., Wu, Q., & Lin, W., et al. (2023). \u03b2-Sitosterol activates autophagy to inhibit the development of hepatocellular carcinoma by regulating the complement C5a receptor 1\/alpha fetoprotein axis. European Journal of Pharmacology, 957, 175983.","journal-title":"European Journal of Pharmacology"},{"issue":"5","key":"1559_CR43","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.3892\/or.2017.5508","volume":"37","author":"X Wang","year":"2017","unstructured":"Wang, X., Li, M., Hu, M., Wei, P., & Zhu, W. (2017). BAMBI overexpression together with \u03b2-sitosterol ameliorates NSCLC via inhibiting autophagy and inactivating TGF-\u03b2\/Smad2\/3 pathway. Oncology Reports, 37(5), 3046\u20133054.","journal-title":"Oncology Reports"},{"key":"1559_CR44","volume":"12","author":"BH Liu","year":"2021","unstructured":"Liu, B. H., Tu, Y., Ni, G. X., Yan, J., Yue, L., & Li, Z. L., et al. (2021). Total flavones of Abelmoschus manihot ameliorates podocyte pyroptosis and injury in high glucose conditions by targeting METTL3-Dependent m(6)A modification-mediated NLRP3-inflammasome activation and PTEN\/PI3K\/Akt signaling. Frontiers in Pharmacology, 12, 667644.","journal-title":"Frontiers in Pharmacology"},{"issue":"180","key":"1559_CR45","doi-asserted-by":"crossref","first-page":"150","DOI":"10.24976\/Discov.Med.202436180.14","volume":"36","author":"D Qiu","year":"2024","unstructured":"Qiu, D., Gao, L., Zhang, S., Zhu, Y., & Lin, G. (2024). \u03b2-sitosterol alleviates the proliferation and migration of cystitis glandularis-associated cells by targeting HMGCR to induce NLRP3-dependent pyroptosis. Discovery Medicine, 36(180), 150\u2013159.","journal-title":"Discovery Medicine"},{"issue":"11","key":"1559_CR46","doi-asserted-by":"crossref","first-page":"12515","DOI":"10.1096\/fj.201802805RR","volume":"33","author":"Y An","year":"2019","unstructured":"An, Y., Zhang, H., Wang, C., Jiao, F., Xu, H., & Wang, X., et al. (2019). Activation of ROS\/MAPKs\/NF-\u03baB\/NLRP3 and inhibition of efferocytosis in osteoclast-mediated diabetic osteoporosis. FASEB Journal, 33(11), 12515\u201312527.","journal-title":"FASEB Journal"},{"key":"1559_CR47","volume":"2022","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y., Yao, H., Li, C., Sun, W., Chen, X., & Cao, Y., et al. (2022). Gandi capsule improved podocyte lipid metabolism of diabetic nephropathy mice through SIRT1\/AMPK\/HNF4A pathway. Oxidative Medicine and Cellular Longevity, 2022, 6275505.","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"1559_CR48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2024.106543","volume":"243","author":"W Yang","year":"2024","unstructured":"Yang, W., Tian, Y., Yang, M., Mauck, J., Loor, J. J., & Jia, B., et al. (2024). \u03b2-sitosterol alleviates high fatty acid-induced lipid accumulation in calf hepatocytes by regulating cholesterol metabolism. The Journal of Steroid Biochemistry and Molecular Biology, 243, 106543.","journal-title":"The Journal of Steroid Biochemistry and Molecular Biology"},{"key":"1559_CR49","volume":"118","author":"M Wu","year":"2021","unstructured":"Wu, M., Yang, Z., Zhang, C., Shi, Y., Han, W., & Song, S., et al. (2021). Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy. Metabolism, 118, 154748.","journal-title":"Metabolism"},{"issue":"6","key":"1559_CR50","doi-asserted-by":"crossref","first-page":"a001651","DOI":"10.1101\/cshperspect.a001651","volume":"1","author":"T Lawrence","year":"2009","unstructured":"Lawrence, T. (2009). The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harbor Perspectives in Biology, 1(6), a001651.","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"issue":"8","key":"1559_CR51","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/ni.2065","volume":"12","author":"A Oeckinghaus","year":"2011","unstructured":"Oeckinghaus, A., Hayden, M. S., & Ghosh, S. (2011). Crosstalk in NF-\u03baB signaling pathways. Nature Immunology, 12(8), 695\u2013708.","journal-title":"Nature Immunology"},{"issue":"4","key":"1559_CR52","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3390\/ph14040307","volume":"14","author":"SY Alomar","year":"2021","unstructured":"Alomar, S. Y., Gheit, R., Enan, E. T., El-Bayoumi, K. S., Shoaeir, M. Z., & Elkazaz, A. Y., et al. (2021). Novel mechanism for memantine in attenuating diabetic neuropathic pain in mice via downregulating the spinal HMGB1\/TRL4\/NF-kB inflammatory axis. Pharmaceuticals, 14(4), 307.","journal-title":"Pharmaceuticals"},{"issue":"5","key":"1559_CR53","doi-asserted-by":"crossref","first-page":"e97985","DOI":"10.1371\/journal.pone.0097985","volume":"9","author":"J Ma","year":"2014","unstructured":"Ma, J., Chadban, S. J., Zhao, C. Y., Chen, X., Kwan, T., & Panchapakesan, U., et al. (2014). TLR4 activation promotes podocyte injury and interstitial fibrosis in diabetic nephropathy. PLoS One, 9(5), e97985.","journal-title":"PLoS One"},{"key":"1559_CR54","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.2147\/DDDT.S411211","volume":"17","author":"M Guo","year":"2023","unstructured":"Guo, M., Gao, J., Jiang, L., & Dai, Y. (2023). Astragalus polysaccharide ameliorates renal inflammatory responses in a diabetic nephropathy by suppressing the TLR4\/NF-\u03baB Pathway. Drug Design Development and Therapy, 17, 2107\u20132118.","journal-title":"Drug Design Development and Therapy"},{"issue":"2","key":"1559_CR55","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3724\/abbs.2023251","volume":"56","author":"Y Xie","year":"2024","unstructured":"Xie, Y., Chen, Z., Li, S., Yan, M., He, W., & Li, L., et al. (2024). A network pharmacology- and transcriptomics-based investigation reveals an inhibitory role of \u03b2-sitosterol in glioma via the EGFR\/MAPK signaling pathway. Acta Biochimica et Biophysica Sinica, 56(2), 223\u2013238.","journal-title":"Acta Biochimica et Biophysica Sinica"},{"key":"1559_CR56","volume":"12","author":"H Huang","year":"2021","unstructured":"Huang, H., Zhang, G., & Ge, Z. (2021). lncRNA MALAT1 promotes renal fibrosis in diabetic nephropathy by targeting the miR-2355-3p\/IL6ST axis. Frontiers in Pharmacology, 12, 647650.","journal-title":"Frontiers in Pharmacology"},{"key":"1559_CR57","volume":"2021","author":"H Shi","year":"2021","unstructured":"Shi, H., Tian, S., & Tian, H. (2021). Network pharmacology interpretation of Fuzheng-Jiedu decoction against colorectal cancer. Evid-based Complementary and Alternative Medicine, 2021, 4652492.","journal-title":"Evid-based Complementary and Alternative Medicine"},{"key":"1559_CR58","volume":"140","author":"EAM El-Shoura","year":"2024","unstructured":"El-Shoura, E. A. M., Abdelzaher, L. A., Mahmoud, N. I., Farghaly, O. A., Sabry, M., & Girgis Shahataa, M., et al. (2024). Combined sulforaphane and \u03b2-sitosterol mitigate olanzapine-induced metabolic disorders in rats: Insights on FOXO, PI3K\/AKT, JAK\/STAT3, and MAPK signaling pathways. International Immunopharmacology, 140, 112904.","journal-title":"International Immunopharmacology"},{"key":"1559_CR59","volume":"9","author":"W Wu","year":"2022","unstructured":"Wu, W., Liu, W., Wang, H., Wang, W., Chu, W., & Jin, J. (2022). \u03b2-sitosterol inhibits trimethylamine production by regulating the gut microbiota and attenuates atherosclerosis in ApoE(-\/-) mice. Frontiers in Cardiovascular Medicine, 9, 986905.","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"10","key":"1559_CR60","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.bbalip.2018.08.004","volume":"1863","author":"S Feng","year":"2018","unstructured":"Feng, S., Dai, Z., Liu, A. B., Huang, J., Narsipur, N., & Guo, G., et al. (2018). Intake of stigmasterol and \u03b2-sitosterol alters lipid metabolism and alleviates NAFLD in mice fed a high-fat western-style diet. Biochimica et Biophysica Acta. Molecular and Cell Biology of Lipids, 1863(10), 1274\u20131284.","journal-title":"Biochimica et Biophysica Acta. Molecular and Cell Biology of Lipids"},{"issue":"5","key":"1559_CR61","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.advnut.2023.05.013","volume":"14","author":"H Wang","year":"2023","unstructured":"Wang, H., Wang, Z., Zhang, Z., Liu, J., & Hong, L. (2023). \u03b2-sitosterol as a promising anticancer agent for chemoprevention and chemotherapy: Mechanisms of action and future prospects. Advances in Nutrition, 14(5), 1085\u20131110.","journal-title":"Advances in Nutrition"},{"issue":"5","key":"1559_CR62","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3390\/nu14051035","volume":"14","author":"RB Kreider","year":"2022","unstructured":"Kreider, R. B., J\u00e4ger, R., & Purpura, M. (2022). Bioavailability, efficacy, safety, and regulatory status of creatine and related compounds: A critical review. Nutrients, 14(5), 1035.","journal-title":"Nutrients"},{"issue":"4","key":"1559_CR63","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3390\/pharmaceutics10040232","volume":"10","author":"M Andima","year":"2018","unstructured":"Andima, M., Costabile, G., Isert, L., Ndakala, A. J., Derese, S., & Merkel, O. M. (2018). Evaluation of \u03b2-sitosterol loaded PLGA and PEG-PLA nanoparticles for effective treatment of breast cancer: Preparation, physicochemical characterization, and antitumor activity. Pharmaceutics, 10(4), 232.","journal-title":"Pharmaceutics"},{"issue":"Pt B","key":"1559_CR64","volume":"162","author":"L Catelli Rocha Torres","year":"2022","unstructured":"Catelli Rocha Torres, L., Giovanini de Oliveira Sartori, A., de Souza Silva, A. P., & Matias de Alencar, S. (2022). Bioaccessibility and uptake\/epithelial transport of vitamin E: Discoveries and challenges of in vitro and ex vivo assays. Food Research International, 162(Pt B), 112143.","journal-title":"Food Research International"},{"issue":"4","key":"1559_CR65","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3390\/pharmaceutics12040386","volume":"12","author":"Y Soleimanian","year":"2020","unstructured":"Soleimanian, Y., Goli, S. A. H., Varshosaz, J., Di Cesare Mannelli, L., Ghelardini, C., & Cirri, M., et al. (2020). \u03b2-sitosterol loaded nanostructured lipid carrier: Physical and oxidative stability, in vitro simulated digestion and hypocholesterolemic activity. Pharmaceutics, 12(4), 386.","journal-title":"Pharmaceutics"},{"issue":"4","key":"1559_CR66","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/medicines3040029","volume":"3","author":"MS Bin Sayeed","year":"2016","unstructured":"Bin Sayeed, M. S., Karim, S. M. R., Sharmin, T., & Morshed, M. M. (2016). Critical analysis on characterization, systemic effect, and therapeutic potential of beta-sitosterol: A plant-derived orphan phytosterol. Medicines, 3(4), 29.","journal-title":"Medicines"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01559-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-024-01559-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01559-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T12:29:28Z","timestamp":1740745768000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-024-01559-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,19]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["1559"],"URL":"https:\/\/doi.org\/10.1007\/s12013-024-01559-4","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,19]]},"assertion":[{"value":"17 September 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}